These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3080356)

  • 1. Defective release of vascular plasminogen activator in patients with gynecologic malignancies.
    Doman KA; Gore M; Miller KE; Soong SJ; Clarke-Pearson DL; Pizzo SV
    Gynecol Oncol; 1986 Feb; 23(2):141-8. PubMed ID: 3080356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular plasminogen activator levels and thromboembolic disease in patients with gynecologic malignancies.
    Gore M; Miller KE; Soong SJ; Clarke-Pearson DL; Pizzo SV
    Am J Obstet Gynecol; 1984 Aug; 149(8):830-4. PubMed ID: 6540521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Releasable vascular plasminogen activator and thrombotic strokes.
    Pizzo SV; Petruska DB; Doman KA; Soong SJ; Fuchs HE
    Am J Med; 1985 Oct; 79(4):407-11. PubMed ID: 3931468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Release of tissue plasminogen activator and its fast-acting inhibitor in defective fibrinolysis.
    Pizzo SV; Fuchs HE; Doman KA; Petruska DB; Berger H
    Arch Intern Med; 1986 Jan; 146(1):188-91. PubMed ID: 2935105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline fibrinolytic state and the risk of future venous thrombosis. A prospective study of endogenous tissue-type plasminogen activator and plasminogen activator inhibitor.
    Ridker PM; Vaughan DE; Stampfer MJ; Manson JE; Shen C; Newcomer LM; Goldhaber SZ; Hennekens CH
    Circulation; 1992 May; 85(5):1822-7. PubMed ID: 1572039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on the plasma plasminogen activators in patients with malignant gynecologic tumors].
    Shimada H; Ikeuchi M; Suwa M; Michimoto T; Ono Y; Tanada S; Himeno K; Hoshino T; Takashima E
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1353-9. PubMed ID: 2511260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombolytic and pharmacokinetic properties of chimeric tissue-type and urokinase-type plasminogen activators.
    Collen D; Lu HR; Lijnen HR; Nelles L; Stassen JM
    Circulation; 1991 Sep; 84(3):1216-34. PubMed ID: 1909220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenteric vein thrombosis and vascular plasminogen activator.
    Boyko OB; Pizzo SV
    Arch Pathol Lab Med; 1983 Oct; 107(10):541-2. PubMed ID: 6688517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered endothelial function following the Fontan procedure.
    Binotto MA; Maeda NY; Lopes AA
    Cardiol Young; 2008 Feb; 18(1):70-4. PubMed ID: 18093358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of Venous Thromboembolism After Laparoscopic Surgery for Gynecologic Malignancy.
    Mahdi H; Aljebori Q; Lockart D; Moulton L
    J Minim Invasive Gynecol; 2016; 23(7):1057-1062. PubMed ID: 27353413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective release of tissue plasminogen activator in systemic and cutaneous vasculitis.
    Jordan JM; Allen NB; Pizzo SV
    Am J Med; 1987 Mar; 82(3):397-400. PubMed ID: 3103439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pregnancy-induced changes in the fibrinolytic balance: evidence for defective release of tissue plasminogen activator and increased levels of the fast-acting tissue plasminogen activator inhibitor.
    Gore M; Eldon S; Trofatter KF; Soong SJ; Pizzo SV
    Am J Obstet Gynecol; 1987 Mar; 156(3):674-80. PubMed ID: 3493696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of thrombolysis using tissue plasminogen activator in lower extremity deep venous thrombosis with concomitant femoral-popliteal venous segment involvement.
    Lin M; Hsieh JCF; Hanif M; McDaniel A; Chew DK
    J Vasc Surg Venous Lymphat Disord; 2017 Sep; 5(5):613-620. PubMed ID: 28818211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypofibrinolysis in patients with a history of idiopathic deep vein thrombosis and/or pulmonary embolism.
    Grimaudo V; Bachmann F; Hauert J; Christe MA; Kruithof EK
    Thromb Haemost; 1992 Apr; 67(4):397-401. PubMed ID: 1631786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative thrombolytic properties of tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (u-PA) and K1K2Pu (a t-PA/u-PA chimera) in a combined arterial and venous thrombosis model in the dog.
    Lu HR; Wu Z; Pauwels P; Lijnen HR; Collen D
    J Am Coll Cardiol; 1992 May; 19(6):1350-9. PubMed ID: 1342779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Risk and prevention of thromboembolism complications in gynecologic malignancies].
    Graf AH; Graf B; Traun H; Staudach A
    Gynakol Geburtshilfliche Rundsch; 1996; 36(1):37-9. PubMed ID: 8737522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defective release of tissue plasminogen activator in patients with sickle cell anemia.
    Phillips G; Mitchell LB; Pizzo SV
    Am J Hematol; 1988 Sep; 29(1):52-3. PubMed ID: 3140656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. External pneumatic compression and fibrinolysis in abdominal surgery.
    Cahan MA; Hanna DJ; Wiley LA; Cox DK; Killewich LA
    J Vasc Surg; 2000 Sep; 32(3):537-43. PubMed ID: 10957661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrophie blanche. A disorder associated with defective release of tissue plasminogen activator.
    Pizzo SV; Murray JC; Gonias SL
    Arch Pathol Lab Med; 1986 Jun; 110(6):517-9. PubMed ID: 3085632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between plasma levels of tissue plasminogen activator and postoperative deep vein thrombosis--influence of prophylaxis with a low molecular weight heparin. The Venous Thrombosis Group.
    Sørensen JV; Borris LC; Lassen MR; Christiansen HM; Schøtt P; Olsen AD; Neerstrand HS
    Thromb Res; 1990 Jul; 59(1):131-8. PubMed ID: 2169077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.